Search - tctmd.com

Displaying 61 - 80 of 722

Sort: Relevancy | Date

Presentation TCT 2024

What’s Next - Going into 2025

Presenter: Vijay Iyer

October 28, 2024

Presentation TCT 2024

Science of Ultrasound RDN

Presenter: Michael Joner

October 28, 2024

Presentation TCT 2024

Getting Started: Establishing a Patient Care Pathway

Presenter: Matheen Khuddus

October 28, 2024

Presentation TCT 2024

Building Real-world Clinical Evidence: Global Paradise System (GPS) Registry

Presenter: Naomi Fisher

October 28, 2024

Presentation TCT 2024

Ultrasound Renal Denervation in Hypertension – From Paradise to Sonivie

Presenter: Naomi Fisher

October 28, 2024

Presentation TCT 2024

Radiofrequency Renal Denervation in Hypertension – From Symplicity to Iberis HTN

Presenter: Lucas Lauder

October 28, 2024

Presentation TCT 2024

Multiorgan Denervation in Hypertension and Beyond – From Renal to Hepatic

Presenter: Raven Voora

October 28, 2024

Presentation TCT 2024

Alternative Renal Denervation Devices – From Ablative Solutions to Verve

Presenter: Michael Weber

October 28, 2024

Presentation TCT 2024

Final Results of the Novel Healing-Targeted DES With Synchronized Antiproliferative Drug Delivery to Target Smooth Muscle Cell Proliferation After DES Implantation in Coronary Artery Disease: 5-Year Results of the PIONEER III Trial

Presenter: Thomas Sharp

October 28, 2024

Presentation TCT 2024

TCT 486: Ultrasound Based Renal Denervation Reduces Blood Pressure in Patients With Chronic Kidney Disease: Results of a Multicenter Prospective Randomized Sham-Controlled Blinded Investigator Initiated Trial

Presenter: Roland Schmieder

October 28, 2024

Presentation TCT 2024

TCT 485: Device-Related Adverse Events and Modes of Failure Related to Renal Denervation Systems: Insights From Analysis of the FDA MAUDE Database

Presenter: Manasa Jasti

October 28, 2024

Presentation TCT 2024

TCT 484: Twelve Week Safety and Efficacy of a Novel Extravascular Bi-lateral Renal Denervation Device in a Porcine Model at Nominal Dose

Presenter: Abraham Tzafriri

October 28, 2024

Presentation TCT 2024

TCT 483: One Year Follow-Up Effect of Renal Sympathetic Denervation After Percutaneous Coronary Intervention in Patients With Resistant Hypertension and Type 2 Diabetes Mellitus

Presenter: Daria Feshchenko

October 28, 2024

Presentation TCT 2024

TCT 482: Anatomical Predictors for Blood Pressure Outcome After Endovascular Ultrasound Renal Denervation

Presenter: Karl Fengler

October 28, 2024

Presentation TCT 2024

TCT 481: Renal Artery Imaging Through Long-Term Follow-Up Following Radiofrequency Renal Denervation: Results From the SPYRAL Clinical Trial Program

Presenter: Felix Mahfoud

October 28, 2024

Presentation TCT 2024

TCT 480: Blood Pressure Reductions by Radiofrequency Renal Denervation Procedural Characteristics: Pooled 24-Month Results From the SYMPLICITY Clinical Program

Presenter: Felix Mahfoud

October 28, 2024

Presentation TCT 2024

TCT 466: Renal Artery Denervation Combined With Pulmonary Vein Isolation in Patients With Heart Failure and Atrial Fibrillation: A Randomized Trial Preliminary Results and Study Design

Presenter: Tomasz Skowerski

October 28, 2024

Presentation TCT 2024

Tips and Tricks for Performing a Safe and Effective Renal Denervation (With Video Examples)

Presenter: Flavio Ribichini

October 28, 2024

Presentation TCT 2024

TCT 1280: Extravascular Renal Denervation in Patients With Resistant Hypertension: Challenging Experience From the First-in-Human Trial in Korea

Presenter: Chang Wook Jeong

October 28, 2024

Presentation TCT 2024

Long-term Safety and Efficacy of Radiofrequency Renal Denervation in the Presence of Antihypertensive Drugs: 24-Month Results From the SPYRAL HTN-ON MED Randomized Trial

Presenter: David Kandzari

October 28, 2024

Advertisement

What’s Next - Going into 2025

Science of Ultrasound RDN

Getting Started: Establishing a Patient Care Pathway

Building Real-world Clinical Evidence: Global Paradise System (GPS) Registry

Ultrasound Renal Denervation in Hypertension – From Paradise to Sonivie

Radiofrequency Renal Denervation in Hypertension – From Symplicity to Iberis HTN

Multiorgan Denervation in Hypertension and Beyond – From Renal to Hepatic

Alternative Renal Denervation Devices – From Ablative Solutions to Verve

Final Results of the Novel Healing-Targeted DES With Synchronized Antiproliferative Drug Delivery to Target Smooth Muscle Cell Proliferation After DES Implantation in Coronary Artery Disease: 5-Year Results of the PIONEER III Trial

TCT 486: Ultrasound Based Renal Denervation Reduces Blood Pressure in Patients With Chronic Kidney Disease: Results of a Multicenter Prospective Randomized Sham-Controlled Blinded Investigator Initiated Trial

TCT 485: Device-Related Adverse Events and Modes of Failure Related to Renal Denervation Systems: Insights From Analysis of the FDA MAUDE Database

TCT 484: Twelve Week Safety and Efficacy of a Novel Extravascular Bi-lateral Renal Denervation Device in a Porcine Model at Nominal Dose

TCT 483: One Year Follow-Up Effect of Renal Sympathetic Denervation After Percutaneous Coronary Intervention in Patients With Resistant Hypertension and Type 2 Diabetes Mellitus

TCT 482: Anatomical Predictors for Blood Pressure Outcome After Endovascular Ultrasound Renal Denervation

TCT 481: Renal Artery Imaging Through Long-Term Follow-Up Following Radiofrequency Renal Denervation: Results From the SPYRAL Clinical Trial Program

TCT 480: Blood Pressure Reductions by Radiofrequency Renal Denervation Procedural Characteristics: Pooled 24-Month Results From the SYMPLICITY Clinical Program

TCT 466: Renal Artery Denervation Combined With Pulmonary Vein Isolation in Patients With Heart Failure and Atrial Fibrillation: A Randomized Trial Preliminary Results and Study Design

Tips and Tricks for Performing a Safe and Effective Renal Denervation (With Video Examples)

TCT 1280: Extravascular Renal Denervation in Patients With Resistant Hypertension: Challenging Experience From the First-in-Human Trial in Korea

Long-term Safety and Efficacy of Radiofrequency Renal Denervation in the Presence of Antihypertensive Drugs: 24-Month Results From the SPYRAL HTN-ON MED Randomized Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content